HCV Test Types and Innovations

Updated: February, 2018


Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy 
E. Sagnelli, L. Alessio, C. Sagnelli, L. Gualdieri, M. Pisaturo, C. Minichini, G. Di Caprio, M. Starace, L. Onorato, G. Scotto, M. Macera and N. Coppola
Annals of hepatology January-February 2018;17(1):47-53. doi: 10.5604/01.3001.0010.7534

Vertical transmission of hepatitis C: Testing and health-care engagement 
S. Reid, C. A. Day, D. G. Bowen, J. Minnis, J. Ludlow, S. Jacobs, A. Gordon and P. S. Haber
Journal of paediatrics and child health Jan 2 2018;():. doi: 10.1111/jpc.13832

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV 
V. K. Nguyen, Z. R. Greenwald, H. Trottier, M. Cadieux, A. Goyette, M. Beauchemin, L. Charest, D. Longpre, S. Lavoie, H. G. Tossa and R. Thomas
AIDS (London, England) Feb 20 2018;32(4):523-530. doi: 10.1097/qad.0000000000001718

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries 
H. Leblebicioglu, J. E. Arends, R. Ozaras, G. Corti, L. Santos, C. Boesecke, A. Ustianowski, A. S. Duberg, S. Ruta, N. N. Salkic, P. Husa, I. Lazarevic, J. A. Pineda, N. Y. Pshenichnaya, T. Tsertswadze, M. Maticic, E. Puca, G. Abuova, J. Gervain, R. Bayramli, S. Ahmeti, M. Koulentaki, B. Kilani, A. Vince, F. Negro, M. Sunbul and D. Salmon
Antiviral research Feb 2018;150():9-14. doi: 10.1016/j.antiviral.2017.12.001

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia 
T. Kikvidze, N. Luhmann, E. Avril, M. Butsashvili, K. Labartkava, A. Etienne, D. Le Pluart, I. Inaridze, A. Gamezardashvili, D. Kharshiladze and J. Bouscaillou
The International journal on drug policy Feb 2018;52():16-19. doi: 10.1016/j.drugpo.2017.11.014

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries 
A. M. Falla, A. A. Ahmad, E. Duffell, T. Noori and I. K. Veldhuijzen
BMC infectious diseases Jan 16 2018;18(1):42. doi: 10.1186/s12879-017-2908-5

Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings 
L. Duchesne and K. Lacombe
Journal of viral hepatitis Feb 2018;25(2):108-117. doi: 10.1111/jvh.12827 Epub 2017 Dec 27

Hepatitis C Screening: From Modeling to Public Health Policy 
J. Chhatwal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jan 18 2018;66(3):385-386. doi: 10.1093/cid/cix800

The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice 
A. Aim-Eusebi, E. Prothon, C. Majerholc, D. Barger, Y. Yazdanpanah and J. P. Aubert
The European journal of general practice Dec 2018;24(1):60-67. doi: 10.1080/13814788.2017.1400529 Epub 2017 Nov 27

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there? 
J. Grebely, G. J. Dore, S. Morin, J. K. Rockstroh and M. B. Klein
Journal of the International AIDS Society Jul 28 2017;20(1):22146. doi: 10.7448/ias.20.1.22146

Developing a community HCV service: project ITTREAT (integrated community-based test - stage - TREAT) service for people who inject drugs 
A. Hashim, M. O'Sullivan, H. Williams and S. Verma
Primary health care research & development Dec 4 2017;():1-11. doi: 10.1017/s1463423617000731

Blood borne virus testing of 2250 patients in an unusual, repeated dental patient notification exercise: challenges faced and lessons learnt 
H. J. Henderson, L. Hopps and K. M. Roy
Public health Oct 2017;151():74-80. doi: 10.1016/j.puhe.2017.06.015 Epub 2017 Jul 24

Continuum of hepatitis C care in France: A 20-year cohort study 
C. Hermetet, F. Dubois, C. Gaudy-Graffin, Y. Bacq, B. Royer, C. Gaborit, L. D'Alteroche, J. C. Desenclos, P. Roingeard and L. Grammatico-Guillon
PloS one 2017;12(8):e0183232. doi: 10.1371/journal.pone.0183232

Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina 
H. Hodzic, A. Bajramovic, Z. Obradovic and M. Mahmic-Kaknjo
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina Feb 1 2017;14(1):73-78. doi: 10.17392/880-16

Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center 
N. Y. Isho, M. D. Kachlic, J. C. Marcelo and M. T. Martin
Journal of the American Pharmacists Association : JAPhA May - Jun 2017;57(3s):S259-s264. doi: 10.1016/j.japh.2017.03.006

MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection 
E. Hoornenborg, R. C. A. Achterbergh, M. F. Schim van der Loeff, U. Davidovich, A. Hogewoning, H. J. C. de Vries, J. Schinkel, M. Prins and T. J. W. van de Laar
AIDS (London, England) Jul 17 2017;31(11):1603-1610. doi: 10.1097/qad.0000000000001522

[Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 15 October 2016] 
B. Hunyady, Z. Gerlei, J. Gervain, G. Horvath, G. Lengyel, A. Par, Z. Peter, L. Rokusz, F. Schneider, F. Szalay, I. Tornai, K. Werling and M. Makara
Orvosi hetilap Feb 2017;158(Suppl 1):3-22. doi: 10.1556/650.2017.30688

Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries 
A. Ishizaki, J. Bouscaillou, N. Luhmann, S. Liu, R. Chua, N. Walsh, S. Hess, E. Ivanova, T. Roberts and P. Easterbrook
BMC infectious diseases Nov 1 2017;17(Suppl 1):696. doi: 10.1186/s12879-017-2767-0

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs 
J. Grebely, J. Bruneau, J. V. Lazarus, O. Dalgard, P. Bruggmann, C. Treloar, M. Hickman, M. Hellard, T. Roberts, L. Crooks, H. Midgard, S. Larney, L. Degenhardt, H. Alho, J. Byrne, J. F. Dillon, J. J. Feld, G. Foster, D. Goldberg, A. R. Lloyd, J. Reimer, G. Robaeys, M. Torrens, N. Wright, I. Maremmani, B. L. Norton, A. H. Litwin and G. J. Dore
The International journal on drug policy Sep 2017;47():51-60. doi: 10.1016/j.drugpo.2017.05.019

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study 
N. Islam, M. Krajden, J. Shoveller, P. Gustafson, M. Gilbert, J. A. Buxton, J. Wong, M. W. Tyndall and N. Z. Janjua
The lancet. Gastroenterology & hepatology Mar 2017;2(3):200-210. doi: 10.1016/s2468-1253(16)30182-0 Epub 2016 Dec 23

Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use Drugs 
M. G. Hofmeister, J. R. Havens and A. M. Young
The journal of primary prevention Oct 2017;38(5):481-494. doi: 10.1007/s10935-017-0483-6

Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis 
J. Grebely, T. L. Applegate, P. Cunningham and J. J. Feld
Expert review of molecular diagnostics Dec 2017;17(12):1109-1115. doi: 10.1080/14737159.2017.1400385

Diagnosis of viral hepatitis 
P. J. Easterbrook, T. Roberts, A. Sands and R. Peeling
Current opinion in HIV and AIDS May 2017;12(3):302-314. doi: 10.1097/coh.0000000000000370

[HBV, HCV, and HIV infection prevalence among prison staff in the light of occupational risk factors] 
M. Ganczak and Z. Szych
Medycyna pracy Jun 27 2017;68(4):507-516. doi: 10.13075/mp.5893.00539 Epub 2017 May 15

Lipid testing in infectious diseases: possible role in diagnosis and prognosis 
S. Filippas-Ntekouan, E. Liberopoulos and M. Elisaf
Infection Oct 2017;45(5):575-588. doi: 10.1007/s15010-017-1022-3

Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population 
O. Ethgen, Y. Sanchez Gonzalez, G. Jeanblanc, A. Duguet, D. Misurski and T. Juday
Journal of medical economics Feb 2017;20(2):162-170. doi: 10.1080/13696998.2016.1232725 Epub 2016 Sep 21

Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015 
A. Jablonka, P. Solbach, M. Wobse, M. P. Manns, R. E. Schmidt, H. Wedemeyer, M. Cornberg, G. M. N. Behrens and S. Hardtke
European journal of gastroenterology & hepatology Aug 2017;29(8):939-945. doi: 10.1097/meg.0000000000000889

A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases 
A. Ducancelle, V. Leroy, J. Vergniol, N. Sturm, B. Le Bail, J. P. Zarski, E. Nguyen Khac, D. Salmon, V. de Ledinghen and P. Cales
Journal of clinical gastroenterology Aug 2017;51(7):639-649. doi: 10.1097/mcg.0000000000000788

Bridging the silos in HIV and Hepatitis C prevention: a cross-provincial qualitative study 
A. Dube, G. Harris, J. Gahagan and S. Doucet
International journal of public health Sep 2017;62(7):739-746. doi: 10.1007/s00038-016-0914-9 Epub 2016 Oct 25

Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project 
B. J. Dong, M. Lopez and J. Cocohoba
Journal of the American Pharmacists Association : JAPhA Jul - Aug 2017;57(4):510-515.e2. doi: 10.1016/j.japh.2017.04.463

Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis 
S. M. Davis, S. Daily, A. L. Kristjansson, G. A. Kelley, K. Zullig, A. Baus, D. Davidov and M. Fisher
Harm reduction journal May 17 2017;14(1):25. doi: 10.1186/s12954-017-0156-z

What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland 
M. Czerwinski, P. Grabarczyk, M. Stepien, D. Kubicka-Russel, K. Tkaczuk, E. Brojer and M. Rosinska
Transfusion Aug 2017;57(8):1998-2006. doi: 10.1111/trf.14163 Epub 2017 May 28

Prevalence rates of six selected infectious diseases among African migrants and refugees: a systematic review and meta-analysis 
A. Chernet, J. Utzinger, V. Sydow, N. Probst-Hensch, D. H. Paris, N. D. Labhardt and A. Neumayr
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology Oct 28 2017;():. doi: 10.1007/s10096-017-3126-1

Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade 
A. Bregenzer, A. Conen, J. Knuchel, A. Friedl, F. Eigenmann, M. Naf, P. Ackle, M. Roth and C. A. Fux
Swiss medical weekly Nov 29 2017;147():w14544. doi: 10.4414/smw.2017.14544

Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today 
F. Bartalesi, C. Scire, A. Requena-Mendez, M. A. Abad, D. Buonfrate, R. Caporali, F. Conti, F. Diaz-Gonzalez, C. Fernandez-Espartero, C. Martinez-Fernandez, M. Mascarello, E. Generali, G. Minisola, A. Morrone, J. Munoz, P. Richi, G. Sakellariou, J. Salas Coronas, M. Spinicci, F. Castelli, A. Bartoloni, Z. Bisoffi, F. Gimenez-Sanchez, S. Munoz-Fernandez and M. Matucci-Cerinic
Clinical and experimental rheumatology Sep-Oct 2017;35(5):752-765. doi:

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review 
S. Bajis, G. J. Dore, B. Hajarizadeh, E. B. Cunningham, L. Maher and J. Grebely
The International journal on drug policy Sep 2017;47():34-46. doi: 10.1016/j.drugpo.2017.07.002

Understanding patient perceptions and risk for hepatitis C screening 
S. Grannan
Journal of viral hepatitis Aug 2017;24(8):631-635. doi: 10.1111/jvh.12692

Prison officers' views about hepatitis C testing and treatment: a qualitative enquiry 
K. Jack, N. Islip, P. Linsley, B. Thomson and A. Patterson
Journal of clinical nursing Jul 2017;26(13-14):1861-1868. doi: 10.1111/jocn.13489 Epub 2017 Mar 20

Evaluation of hepatitis C testing in men who have sex with men, and associated risk behaviours, in Manchester, UK 
G. Ireland, S. Higgins, B. Goorney, C. Ward, S. Ahmad, C. Stewart, R. Simmons, S. Lattimore and V. Lee
Sexually transmitted infections Sep 2017;93(6):404-409. doi: 10.1136/sextrans-2016-052876 Epub 2017 Jan 27

Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target? 
M. R. Jovanovic, A. Miljatovic, L. Puskas, S. Kapor and D. L. Puskas
Frontiers in pharmacology 2017;8():437. doi: 10.3389/fphar.2017.00437

The problem of elimination of HCV infections in Poland 
A. Zielinski and M. Rosinska
Przeglad epidemiologiczny 2017;71(1):3-14. doi:

"Tweak Your Order Set!" Implementation of Modified Laboratory Order Set Improves Hepatitis C Virus Screening Rates in People Living With Human Immunodeficiency Virus 
A. G. Wurcel, D. D. Chen, K. K. H. Chui and T. A. Knox
Open forum infectious diseases Spring 2017;4(2):ofx098. doi: 10.1093/ofid/ofx098

Management of chronic hepatitis C in 2017 
L. von Kockritz and J. F. Dufour
Hamostaseologie Aug 7 2017;37(3):186-195. doi: 10.5482/hamo-16-07-0019 Epub 2016 Nov 29

Successful treatment of donor-derived hepatitis C infection in a lung transplant recipient 
N. Theodoropoulos, B. A. Whitson, S. I. Martin, S. Pouch and A. Pope-Harman
Transplant infectious disease : an official journal of the Transplantation Society Apr 2017;19(2):. doi: 10.1111/tid.12659 Epub 2017 Feb 22

Determining the factors associated with blood-borne virus testing of substance misusers presenting to hospital 
E. Tennant, U. Vollmer-Conna, A. Demirkol and J. J. Post
Internal medicine journal Aug 2017;47(8):907-914. doi: 10.1111/imj.13497

Frequency and the risk factors of hepatitis C virus in pregnant women; A hospital based descriptive study in Gadap Town Karachi 
K. Jilani, B. Zulfiqar, Q. B. Memon and M. F. Fahim
Pakistan journal of medical sciences Sep-Oct 2017;33(5):1265-1268. doi: 10.12669/pjms.335.12493

Multidisciplinary managed care networks-Life-saving interventions for hepatitis C patients 
J. M. Tait, H. Wang, B. P. Stephens, M. Miller, P. G. McIntyre, S. Cleary and J. F. Dillon
Journal of viral hepatitis Mar 2017;24(3):207-215. doi: 10.1111/jvh.12633

Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy 
E. Spada, G. Rezza, A. R. Garbuglia, F. L. Lombardo, O. Zuccaro, F. M. Ippolito, E. Cupellaro, S. Capone, M. R. Capobianchi, A. Nicosia, R. Cortese, A. Folgori and A. Mele
Journal of urban health : bulletin of the New York Academy of Medicine Dec 4 2017;():. doi: 10.1007/s11524-017-0207-5

Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade 
N. Scott, J. S. Doyle, D. P. Wilson, A. Wade, J. Howell, A. Pedrana, A. Thompson and M. E. Hellard
The International journal on drug policy Sep 2017;47():107-116. doi: 10.1016/j.drugpo.2017.07.006

Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014 
A. Sanna, Y. Le Strat, F. Roudot-Thoraval, S. Deuffic Burban, P. Carrieri, E. Delarocque-Astagneau and C. Larsen
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin Jul 27 2017;22(30):. doi: 10.2807/1560-7917.es.2017.22.30.30582

Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016 
M. Rosinska, N. Parda, A. Kolakowska, P. Godzik, K. Zakrzewska, K. Madalinski, A. Zielinski, A. Boguradzka, R. Gierczynski and M. Stepien
PloS one 2017;12(9):e0185055. doi: 10.1371/journal.pone.0185055

Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers 
E. I. Reipold, A. Trianni, D. Krakower, S. Ongarello, T. Roberts, P. Easterbrook and C. Denkinger
BMC infectious diseases Nov 1 2017;17(Suppl 1):702. doi: 10.1186/s12879-017-2769-y

Pathways to the elimination of hepatitis C: prioritising access for all 
A. E. Pedrana, R. Sacks-Davis, J. S. Doyle and M. E. Hellard
Expert review of clinical pharmacology Oct 2017;10(10):1023-1026. doi: 10.1080/17512433.2017.1383894

Blood-borne virus transmission in an urban, culturally diverse neighbourhood: results from a cross-sectional bio-behavioural survey using innovative outreach methods in a hard-to-reach population 
E. Peach, S. Cogger, K. Byron, P. Francis, D. O'Keefe, P. Higgs, M. Stoove, K. Elmore, P. Dietze and M. Hellard
Sexual health Oct 12 2017;():. doi: 10.1071/sh16219

Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders 
A. H. Talal, Y. Chen, M. Zeremski, R. Zavala, C. Sylvester, M. Kuhns, L. S. Brown, M. Markatou and G. A. Cloherty
Journal of substance abuse treatment Jul 2017;78():37-42. doi: 10.1016/j.jsat.2017.04.011 Epub 2017 Apr 20

Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinic 
M. R. Parisi, S. Tecco, G. Gastaldi, E. Polizzi, T. D'Amicantonio, S. Negri, I. Gardini, K. Schlusnus, E. Gherlone, P. Cappare and A. Lazzarin
The new microbiologica Oct 2017;40(4):242-245. doi: Epub 2017 Aug 21

Few men who have sex with men (MSM) attending two inner-city clinics were tested for hepatitis C virus (HCV) despite high risk: a retrospective analysis of sexual health screening in East London 
T. J. Pasvol and C. Orkin
Sexually transmitted infections Aug 2017;93(5):326. doi: 10.1136/sextrans-2016-053055 Epub 2017 Jul 20

Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers 
M. A. Konerman, M. Thomson, K. Gray, M. Moore, H. Choxi, E. Seif and A. S. F. Lok
Hepatology (Baltimore, Md.) Dec 2017;66(6):1805-1813. doi: 10.1002/hep.29362 Epub 2017 Sep 14

Socio-demographic, health-related, and individual correlates of diagnostic self-testing by lay people: Results from a representative survey in Germany 
P. Kuecuekbalaban, S. Schmidt, M. Beutel, K. Weidner, M. de Zwaan, E. Braehler and H. Muehlan
PloS one 2017;12(11):e0188653. doi: 10.1371/journal.pone.0188653

Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses 
B. Lange, J. Cohn, T. Roberts, J. Camp, J. Chauffour, N. Gummadi, A. Ishizaki, A. Nagarathnam, E. Tuaillon, P. van de Perre, C. Pichler, P. Easterbrook and C. M. Denkinger
BMC infectious diseases Nov 1 2017;17(Suppl 1):700. doi: 10.1186/s12879-017-2777-y

Hepatitis C virus infection: opportunities for an earlier detection in primary care 
F. Lapi, A. Capogrosso Sansone, S. Mantarro, M. Simonetti, M. Tuccori, C. Blandizzi, A. Rossi, G. Corti, A. Bartoloni, A. Bellia, L. Baiocchi, I. Cricelli and C. Cricelli
European journal of gastroenterology & hepatology Mar 2017;29(3):271-276. doi: 10.1097/meg.0000000000000785

A new method of producing NS5A antigen of hepatitis C virus 
T. V. Kuznetsova, M. S. Smimova, O. A. Leonovich, I. V. Gordeichuk, I. K. Biriukova, M. V. Zylkova, Y. Y. Tyn'o, A. V. Belyakova and A. B. Shevelev
Voprosy virusologii 2017;62(1):17-25. doi:

Late presentation of chronic viral hepatitis for medical care: a consensus definition 
S. Mauss, S. Pol, M. Buti, E. Duffell, C. Gore, J. V. Lazarus, H. L. der Grient, J. Lundgren, A. Mozalevskis, D. Raben, E. Schatz, S. Wiktor and J. K. Rockstroh
BMC medicine May 3 2017;15(1):92. doi: 10.1186/s12916-017-0856-y

Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population 
K. McGonigle, T. Carley and C. Hoff
Journal of racial and ethnic health disparities Dec 29 2017;():. doi: 10.1007/s40615-017-0453-y

Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012 
A. C. Moorman, J. Drobenuic and S. Kamili
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology Apr 2017;89():1-4. doi: 10.1016/j.jcv.2017.01.007 Epub 2017 Jan 30

Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing 
L. Nieto-Aponte, J. Quer, A. Ruiz-Ripa, D. Tabernero, C. Gonzalez, J. Gregori, M. Vila, M. Asensio, D. Garcia-Cehic, G. Ruiz, Q. Chen, L. Ordeig, M. Llorens, M. Saez, J. I. Esteban, R. Esteban, M. Buti, T. Pumarola and F. Rodriguez-Frias
Journal of clinical microbiology Feb 2017;55(2):504-509. doi: 10.1128/jcm.01960-16

Undiagnosed HIV and Hepatitis C infection in people who inject drugs: From new evidence to better practice 
O. Pares-Badell, A. Espelt, C. Folch, X. Majo, V. Gonzalez, J. Casabona and M. T. Brugal
Journal of substance abuse treatment Jun 2017;77():13-20. doi: 10.1016/j.jsat.2017.03.003

Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy 
N. Mangla, R. Mamun and I. S. Weisberg
European journal of gastroenterology & hepatology Nov 2017;29(11):1215-1218. doi: 10.1097/meg.0000000000000950

Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings 
C. S. Kosack and S. Nick
Tropical medicine & international health : TM & IH May 2016;21(5):603-9. doi: 10.1111/tmi.12688 Epub 2016 Mar 29

Acceptance, yield and feasibility of attaching HCV birth cohort screening to colorectal cancer screening in Spain 
F. J. Garcia-Alonso, D. Bonillo-Cambrodon, A. Bermejo, J. Garcia-Martinez, M. Hernandez-Tejero, P. Valer Lopez Fando, B. Piqueras and F. Bermejo
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Oct 2016;48(10):1237-42. doi: 10.1016/j.dld.2016.06.034 Epub 2016 Jul 11

Hepatitis C Treatment and Barriers to Eradication 
M. A. Konerman and A. S. Lok
Clinical and translational gastroenterology Sep 22 2016;7(9):e193. doi: 10.1038/ctg.2016.50

Viral hepatitis screening guideline before biological drug use in rheumatic patients 
O. Karadag, T. Kasifoglu, B. Ozer, S. Kaymakoglu, Y. Kus, M. Inanc, G. Keser and S. Kiraz
European journal of rheumatology Mar 2016;3(1):25-28. doi: 10.5152/eurjrheum.2015.150072 Epub 2015 Oct 28

Screening for Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Treponema pallidum by Blood Testing Using a Bio-Flash Technology-Based Algorithm before Gastrointestinal Endoscopy 
Z. Jun, C. Zhen, Z. QuiuLi, A. YuanQi, V. V. Casado and Y. Fan
Journal of clinical microbiology Dec 2016;54(12):3000-3006. doi: 10.1128/jcm.00986-16

Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients 
D. Hernandez, D. J. Feaster, L. Gooden, A. Douaihy, R. Mandler, S. J. Erickson, T. Kyle, L. Haynes, R. Schwartz, M. Das and L. Metsch
AIDS and behavior Jan 2016;20(1):204-14. doi: 10.1007/s10461-015-1074-2

Hepatitis C treatment as prevention: evidence, feasibility, and challenges 
B. Hajarizadeh, J. Grebely, M. Martinello, G. V. Matthews, A. R. Lloyd and G. J. Dore
The lancet. Gastroenterology & hepatology Dec 2016;1(4):317-327. doi: 10.1016/s2468-1253(16)30075-9 Epub 2016 Nov 10

Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era 
O. Falade-Nwulia, A. McAdams-Mahmoud, R. Irvin, A. Niculescu, K. R. Page, M. Mix, D. L. Thomas, M. S. Sulkowski and S. H. Mehta
Journal of community medicine & health education Oct 2016;6(5):. doi: 10.4172/2161-0711.1000481 Epub 2016 Oct 28

Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs 
J. A. Barocas, B. P. Linas, A. Y. Kim, J. Fangman and R. P. Westergaard
Open forum infectious diseases Mar 2016;3(2):ofw075. doi: 10.1093/ofid/ofw075

Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications? 
J. Darke, T. Cresswell, S. McPherson and A. Hamoodi
Journal of public health (Oxford, England) Dec 2 2016;38(4):e554-e562. doi: 10.1093/pubmed/fdv178

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care 
S. Chevaliez, L. Poiteau, I. Rosa, A. Soulier, F. Roudot-Thoraval, S. Laperche, C. Hezode and J. M. Pawlotsky
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases May 2016;22(5):459.e1-6. doi: 10.1016/j.cmi.2016.01.009 Epub 2016 Jan 22

Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups 
S. C. Carvalhana, J. Leitao, A. C. Alves, M. Bourbon and H. Cortez-Pinto
European journal of gastroenterology & hepatology Jun 2016;28(6):640-4. doi: 10.1097/meg.0000000000000608

[Not Available] 
P. Bruggmann
Praxis Jul 2016;105(15):885-9. doi: 10.1024/1661-8157/a002424

The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries 
A. Bechini, M. Levi, A. Falla, A. Ahmad, I. Veldhuijzen, E. Tiscione and P. Bonanni
Journal of preventive medicine and hygiene 2016;57(2):E51-60. doi:

Pilot Study: Combining Formal and Peer Education with FibroScan to Increase HCV Screening and Treatment in Persons who use Drugs 
A. Arain, J. De Sousa, K. Corten, R. Verrando, H. Thijs, C. Mathei, F. Buntinx and G. Robaeys
Journal of substance abuse treatment Aug 2016;67():44-9. doi: 10.1016/j.jsat.2016.04.001

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland 
K. Aebi-Popp, A. Duppenthaler, A. Rauch, A. De Gottardi and C. Kahlert
Journal of virus eradication Jan 1 2016;2(1):52-4. doi:

[Which place for point-of-care screening tests in the diagnosis of hepatitis C infection among drug users?] 
N. Lacroix, H. Barraud, C. Gillet, P. Di Patrizio, J. P. Bronowicki, R. Schwan and V. Laprevote
Presse medicale (Paris, France : 1983) Apr 2016;45(4 Pt 1):431-7. doi: 10.1016/j.lpm.2016.01.024

HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions 
P. Easterbrook, C. Johnson, C. Figueroa and R. Baggaley
AIDS reviews Jan-Mar 2016;18(1):3-14. doi:

Prevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Transgender Persons Referred to an Italian Center for Total Sex Reassignment Surgery 
R. Luzzati, M. Zatta, N. Pavan, M. Serafin, C. Maurel, C. Trombetta and F. Barbone
Sexually transmitted diseases Jul 2016;43(7):407-11. doi: 10.1097/olq.0000000000000452

Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom 
M. Harris, E. Ward and C. Gore
Journal of viral hepatitis Jun 2016;23(6):479-86. doi: 10.1111/jvh.12513 Epub 2016 Feb 29

Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life 
B. K. Mossner, B. Staugaard, J. Jensen, S. T. Lillevang, P. B. Christensen and D. K. Holm
World journal of gastroenterology Sep 7 2016;22(33):7604-12. doi: 10.3748/wjg.v22.i33.7604

Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission 
K. L. Young, W. Huang, C. R. Horsburgh, B. P. Linas and S. A. Assoumou
Journal of viral hepatitis Apr 2016;23(4):274-81. doi: 10.1111/jvh.12489 Epub 2015 Nov 17

Hepatitis C Screening in People With Human Immunodeficiency Virus: Lessons Learned From Syphilis Screening 
A. G. Wurcel, D. D. Chen, R. E. Fitzpatrick, P. E. Grasberger, C. H. Kirshner, J. E. Anderson, K. K. Chui and T. A. Knox
Open forum infectious diseases Jan 2016;3(1):ofv215. doi: 10.1093/ofid/ofv215

Newer tests for hepatitis C virus could transform screening 
J. Wise
BMJ (Clinical research ed.) Jun 20 2016;353():i3420. doi: 10.1136/bmj.i3420

Hepatitis C Virus Screening and Emergency Department Length of Stay 
D. A. White, E. S. Anderson, S. K. Pfeil, L. J. Deering, T. Todorovic and T. K. Trivedi
PloS one 2016;11(10):e0164831. doi: 10.1371/journal.pone.0164831

Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study 
R. P. Westergaard, S. J. Hull, A. Merkow, L. K. Stephens, K. R. Hochstatter, H. K. Olson-Streed, L. M. Baker and T. M. Hess
JMIR research protocols Jan 22 2016;5(1):e15. doi: 10.2196/resprot.4830

The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections 
F. M. Wagenlehner, N. H. Brockmeyer, T. Discher, K. Friese and T. A. Wichelhaus
Deutsches Arzteblatt international Jan 11 2016;113(1-02):11-22. doi: 10.3238/arztebl.2016.0011

[What General/Family Medicine Practitioner should Know about Viral Hepatitis] 
J. Vucak and E. Vucak
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti Apr 2016;70(2):87-95. doi:

Breaking Down Barriers to Care in Hepatitis C Virus Infection 
M. Thursz and K. Lacombe
The Journal of infectious diseases Apr 1 2016;213(7):1055-6. doi: 10.1093/infdis/jiv427

Hepatitis C Virus Antibody Testing: Result Availability at Time of Discharge for Emergency Department Patients 
D. A. White, E. S. Anderson, S. K. Pfeil and T. K. Trivedi
Journal of acquired immune deficiency syndromes (1999) Mar 1 2016;71(3):e82-4. doi: 10.1097/qai.0000000000000887

Sex, Drugs, Hepatitis C, and an Urban Emergency Department: January 2016 Annals of Emergency Medicine Journal Club 
D. Silvestri and S. S. Takhar
Annals of emergency medicine Jan 2016;67(1):138-40. doi: 10.1016/j.annemergmed.2015.11.008

Universal screening for chronic hepatitis C virus 
M. L. Shiffman
Liver international : official journal of the International Association for the Study of the Liver Jan 2016;36 Suppl 1():62-6. doi: 10.1111/liv.13012

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care 
B. McMahon, J. Block, T. Block, C. Cohen, A. A. Evans, A. Hosangadi, W. T. London and M. Sherman
Journal of the National Cancer Institute Apr 2016;108(4):. doi: 10.1093/jnci/djv359

Hepatitis C and immigration: a multicentre study 
G. Scotto, O. Armignacco, G. Starnini, R. Francavilla, G. Foti, V. Portelli, M. Mazzeo, N. Minerva, V. Carretta, L. Lo Muzio and V. Fazio
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive Sep 1 2016;24(3):210-6. doi:

What affects response rates in primary healthcare-based programmes? An analysis of individual and unit-related factors associated with increased odds of non-response based on HCV screening in the general population in Poland 
N. Parda, M. Stepien, K. Zakrzewska, K. Madalinski, A. Kolakowska, P. Godzik and M. Rosinska
BMJ open Dec 7 2016;6(12):e013359. doi: 10.1136/bmjopen-2016-013359

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference 
G. Papatheodoridis, H. C. Thomas, C. Golna, M. Bernardi, M. Carballo, M. Cornberg, G. Dalekos, B. Degertekin, S. Dourakis, R. Flisiak, D. Goldberg, C. Gore, I. Goulis, S. Hadziyannis, G. Kalamitsis, P. Kanavos, A. Kautz, I. Koskinas, B. R. Leite, M. Malliori, S. Manolakopoulos, M. Maticic, V. Papaevangelou, A. Pirona, D. Prati, M. Raptopoulou-Gigi, T. Reic, G. Robaeys, E. Schatz, K. Souliotis, Y. Tountas, S. Wiktor, D. Wilson, J. Yfantopoulos and A. Hatzakis
Journal of viral hepatitis Feb 2016;23 Suppl 1():1-12. doi: 10.1111/jvh.12493

Prevalence of hepatitis C among injecting drug users attending drug clinics 
P. O'Connor, G. Judson, R. A. Loan, R. H. Roberts and G. Robinson
The New Zealand medical journal May 6 2016;129(1434):44-8. doi:

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening 
B. L. Norton, W. N. Southern, M. Steinman, B. D. Smith, J. Deluca, Z. Rosner and A. H. Litwin
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Sep 2016;14(9):1356-60. doi: 10.1016/j.cgh.2016.04.017 Epub 2016 Apr 19

Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy 
M. Thomson, M. A. Konerman, H. Choxi and A. S. Lok
Digestive diseases and sciences Dec 2016;61(12):3460-3468. doi: 10.1007/s10620-016-4097-2

Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers 
K. Malm, E. Kragsbjerg and S. Andersson
Transfusion medicine (Oxford, England) Apr 2015;25(2):101-5. doi: 10.1111/tme.12181 Epub 2015 Mar 17

The prevalence of sexually transmitted infections among migrant female patients in Italy 
A. S. Lagana, V. Gavagni, J. V. Musubao and A. Pizzo
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Feb 2015;128(2):165-8. doi: 10.1016/j.ijgo.2014.08.013

[The influence of age, place of living, education and number of earlier pregnancies on attendance of pregnant women to screening tests--questionnaire study] 
M. Kialka, M. Czyzewicz, M. Zuk, T. Milewicz, M. Krzyczkowska-Sendrakowska and M. Pietrus
Przeglad lekarski 2015;72(5):257-62. doi:

The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots 
B. Kauhl, J. Heil, C. J. Hoebe, J. Schweikart, T. Krafft and N. H. Dukers-Muijrers
PloS one 2015;10(9):e0135656. doi: 10.1371/journal.pone.0135656

An audit of hepatitis C service provision in a representative sample of prisons in England 
C. Humphreys, C. Railton, E. O'Moore, M. Lombard and A. Newton
Journal of public health (Oxford, England) Mar 2015;37(1):151-6. doi: 10.1093/pubmed/fdu022

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage 
J. Bottero, A. Boyd, J. Gozlan, F. Carrat, J. Nau, M. D. Pauti, H. Rougier, P. M. Girard and K. Lacombe
Open forum infectious diseases Dec 2015;2(4):ofv162. doi: 10.1093/ofid/ofv162

Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified 
G. R. Foster, C. Gore, M. Hudson, P. Moss, A. Ustianowski, S. Ryder and S. Bhagani
BMJ (Clinical research ed.) Feb 24 2015;350():h998. doi: 10.1136/bmj.h998

Hepatitis C virus infection and its relationship to certain sexual practices in men-who-have-sex-with-men in Spain: results from the European MSM internet survey (EMIS) 
P. Fernandez-Davila, C. Folch, L. Ferrer, R. Soriano, M. Diez and J. Casabona
Enfermedades infecciosas y microbiologia clinica May 2015;33(5):303-10. doi: 10.1016/j.eimc.2014.07.012 Epub 2014 Oct 30

The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature 
J. T. Coats and J. F. Dillon
The International journal on drug policy Nov 2015;26(11):1050-5. doi: 10.1016/j.drugpo.2015.05.001

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected? 
C. Boesecke, D. Grint, V. Soriano, J. D. Lundgren, A. d'Arminio Monforte, V. M. Mitsura, N. Chentsova, V. Hadziosmanovic, O. Kirk, A. Mocroft, L. Peters and J. K. Rockstroh
Liver international : official journal of the International Association for the Study of the Liver Nov 2015;35(11):2384-91. doi: 10.1111/liv.12848 Epub 2015 Apr 29

Screening and treatment for hepatitis C: a balanced perspective 
P. C. Matthews, K. Jeffery, P. Klenerman, E. Barnes and G. Cooke
BMJ (Clinical research ed.) Feb 24 2015;350():h644. doi: 10.1136/bmj.h644

Recommendations for the management of hepatitis C virus infection among people who inject drugs 
J. Grebely, G. Robaeys, P. Bruggmann, A. Aghemo, M. Backmund, J. Bruneau, J. Byrne, O. Dalgard, J. J. Feld, M. Hellard, M. Hickman, A. Kautz, A. Litwin, A. R. Lloyd, S. Mauss, M. Prins, T. Swan, M. Schaefer, L. E. Taylor and G. J. Dore
The International journal on drug policy Oct 2015;26(10):1028-38. doi: 10.1016/j.drugpo.2015.07.005 Epub 2015 Jul 17

World Hepatitis Day: A reminder to screen baby boomers 
J. Newland
The Nurse practitioner Jul 15 2015;40(7):8. doi: 10.1097/01.NPR.0000466504.31747.ea

Cross sectional study of factors associated to self-reported blood-borne infections among drug users 
J. Reyes-Uruena, M. T. Brugal, X. Majo, A. Domingo-Salvany and J. A. Cayla
BMC public health Nov 13 2015;15():1122. doi: 10.1186/s12889-015-2442-6

Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland 
T. C. Prevost, A. M. Presanis, A. Taylor, D. J. Goldberg, S. J. Hutchinson and D. De Angelis
Addiction (Abingdon, England) Aug 2015;110(8):1287-300. doi: 10.1111/add.12948

Should HIV testing week be blood-borne-virus testing week? 
C. Orkin and E. Wallis
The lancet. HIV Dec 2015;2(12):e510-1. doi: 10.1016/s2352-3018(15)00227-1 Epub 2015 Nov 16

Screening for hepatitis C 
C. M. Wray and A. M. Davis
Jama May 12 2015;313(18):1855-6. doi: 10.1001/jama.2015.2833

Where next for hepatitis B and C surveillance? 
S. Z. Wiktor
Journal of viral hepatitis Jul 2015;22(7):571-3. doi: 10.1111/jvh.12400

Hepatitis C screening of men who have sex with men 
C. J. Ward and V. Lee
BMJ (Clinical research ed.) Feb 24 2015;350():h642. doi: 10.1136/bmj.h642

Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era 
A. Teriaky and N. Reau
Clinics in liver disease Nov 2015;19(4):591-604, v. doi: 10.1016/j.cld.2015.06.001 Epub 2015 Aug 25

Sexually transmitted infections and viral hepatitides in patients presenting for non-occupational HIV post-exposure prophylaxis: results of a prospective cohort study 
N. Sivachandran, R. A. Siemieniuk, P. Murphy, A. Sharp, C. Walach, T. Placido and Bogoch,, II
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Nov 2015;40():142-4. doi: 10.1016/j.ijid.2015.10.001

Hepatitis C: a changing epidemic 
G. Wandeler, J. F. Dufour, P. Bruggmann and A. Rauch
Swiss medical weekly 2015;145():w14093. doi: 10.4414/smw.2015.14093

Immigration and viral hepatitis 
S. Sharma, M. Carballo, J. J. Feld and H. L. Janssen
Journal of hepatology Aug 2015;63(2):515-22. doi: 10.1016/j.jhep.2015.04.026

Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease 
M. A. Shaheen and M. Idrees
World journal of hepatology Mar 27 2015;7(3):616-27. doi: 10.4254/wjh.v7.i3.616

Early diagnosis and treatment: the goal of hepatitis C screening 
N. Selvapatt, A. Brown and M. Thursz
BMJ (Clinical research ed.) Feb 24 2015;350():h635. doi: 10.1136/bmj.h635

What psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments? 
P. J. Rowan
World journal of virology Feb 12 2015;4(1):13-6. doi: 10.5501/wjv.v4.i1.13

Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings 
O. T. Sims and B. G. Womack
Social work in public health 2015;30(4):325-35. doi: 10.1080/19371918.2014.1000506 Epub 2015 Mar 26

Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis C outbreak investigation 
F. Gao, E. A. Talbot, C. H. Loring, J. J. Power, J. Dionne-Odom, S. Alroy-Preis, P. Jackson and C. L. Bean
Journal of clinical microbiology Jul 2014;52(7):2650-2. doi: 10.1128/jcm.00132-14 Epub 2014 Apr 30

Sensitivity and specificity of point-of-care rapid combination syphilis-HIV-HCV tests 
K. L. Hess, D. G. Fisher and G. L. Reynolds
PloS one 2014;9(11):e112190. doi: 10.1371/journal.pone.0112190

Is rapid hepatitis C virus testing from corpses a screening option for index persons who have died after mass-casualty incidents in high-prevalence settings in the field? 
R. M. Hagen, B. Wulff, U. Loderstaedt, I. Fengler, H. Frickmann, N. G. Schwarz and S. Polywka
Journal of the Royal Army Medical Corps Sep 2014;160(3):226-31. doi: 10.1136/jramc-2013-000133 Epub 2013 Oct 10

Sexually transmitted infections among women attending a Norwegian Sexual Assault Centre 
C. T. Hagemann, S. A. Nordbo, A. K. Myhre, K. Ormstad and B. Schei
Sexually transmitted infections Jun 2014;90(4):283-9. doi: 10.1136/sextrans-2013-051328 Epub 2014 Feb 24

[The diagnosis of hepatitis C virus infection] 
J. Gervain
Orvosi hetilap Jun 29 2014;155(26):1019-23. doi: 10.1556/oh.2014.29972

Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C 
C. Ford and J. Bressan
BMC infectious diseases 2014;14 Suppl 6():S4. doi: 10.1186/1471-2334-14-s6-s4 Epub 2014 Sep 19

Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs 
M. Alanko Blome, P. Bjorkman, V. Molnegren, P. Hoglund and A. Widell
PloS one 2014;9(5):e97022. doi: 10.1371/journal.pone.0097022

Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients 
P. Brogueira, A. Costa, A. Miranda, S. Peres, T. Baptista, I. Aldir, I. Antunes, F. Ventura, F. Borges and K. Mansinho
Journal of the International AIDS Society 2014;17(4 Suppl 3):19601. doi: 10.7448/ias.17.4.19601

Service improvement. Test drive 

The Health service journal Aug 8 2014;124(6410):suppl 8-9. doi:

Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment 
J. Bouscaillou, J. Champagnat, N. Luhmann, E. Avril, I. Inaridze, V. Miollany, K. Labartkava, I. Kirtadze, M. Butsashvili, G. Kamkamidze and D. Pataut
The International journal on drug policy Sep 2014;25(5):871-8. doi: 10.1016/j.drugpo.2014.01.007 Epub 2014 Jan 23

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study 
E. J. Aspinall, A. Weir, R. Sacks-Davis, T. Spelman, J. Grebely, P. Higgs, S. J. Hutchinson and M. E. Hellard
The International journal on drug policy Jan 2014;25(1):179-82. doi: 10.1016/j.drugpo.2013.08.005

Hepatitis C in European prisons: a call for an evidence-informed response 
A. Arain, G. Robaeys and H. Stover
BMC infectious diseases 2014;14 Suppl 6():S17. doi: 10.1186/1471-2334-14-s6-s17 Epub 2014 Sep 19

Hepatitis C: the next 25years 
M. Houghton
Antiviral research Oct 2014;110():77-8. doi: 10.1016/j.antiviral.2014.06.018 Epub 2014 Jul 17

Sexually transmitted infections in men who have sex with men 
H. J. de Vries
Clinics in dermatology Mar-Apr 2014;32(2):181-8. doi: 10.1016/j.clindermatol.2013.08.001

Hepatitis C for primary care physicians 
M. M. Huffman and A. L. Mounsey
Journal of the American Board of Family Medicine : JABFM Mar-Apr 2014;27(2):284-91. doi: 10.3122/jabfm.2014.02.130165

HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions 
P. Roux, L. Sagaon-Teyssier, C. Lions, L. Fugon, P. Verger and M. P. Carrieri
BMJ open Oct 19 2014;4(10):e005694. doi: 10.1136/bmjopen-2014-005694

Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV 
R. D. Kouyos, A. Rauch, J. Boni, S. Yerly, C. Shah, V. Aubert, T. Klimkait, H. Kovari, A. Calmy, M. Cavassini, M. Battegay, P. L. Vernazza, E. Bernasconi, B. Ledergerber and H. F. Gunthard
International journal of epidemiology Jun 2014;43(3):887-96. doi: 10.1093/ije/dyt276 Epub 2014 Jan 22

Hepatitis C screening 
S. N. Joshi
The Ochsner journal Winter 2014;14(4):664-8. doi:

[Features of the humoral immune response in patients with chronic hepatitis C, spontaneous clearance of hepatitis C virus and false-positive reactions of anti-HCV] 
N. A. Zhandarova
Georgian medical news Jun 2014;(231):38-41. doi:

Experience of acute hepatitis C and HIV co-infection in an inner city clinic in the UK 
C. Ward and V. Lee
Journal of the International AIDS Society 2014;17(4 Suppl 3):19639. doi: 10.7448/ias.17.4.19639

Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010 
A. T. Urbanus, T. J. Van De Laar, R. Geskus, J. W. Vanhommerig, M. S. Van Rooijen, J. Schinkel, T. Heijman, R. A. Coutinho and M. Prins
AIDS (London, England) Mar 13 2014;28(5):781-90. doi: 10.1097/qad.0000000000000126

Complexities of HCV management in the new era of direct-acting antiviral agents 
W. M. Rosenberg, S. Tanwar and P. Trembling
QJM : monthly journal of the Association of Physicians Jan 2014;107(1):17-9. doi: 10.1093/qjmed/hct181 Epub 2013 Sep 23

New hepatitis C therapies: the toolbox, strategies, and challenges 
J. M. Pawlotsky
Gastroenterology May 2014;146(5):1176-92. doi: 10.1053/j.gastro.2014.03.003 Epub 2014 Mar 12

Should we offer routine hepatitis C antibody testing in men who have sex with men? 
C. Ward and V. Lee
Journal of the International AIDS Society 2014;17(4 Suppl 3):19591. doi: 10.7448/ias.17.4.19591

Screening for hepatitis C virus infection in adults 
I. Mabry-Hernandez and S. Blackmer
American family physician Sep 15 2014;90(6):405-6. doi:

Common bile duct dilatation in drug users with chronic hepatitis C is associated with current methadone use 
S. J. Leopold, B. P. Grady, C. E. Lindenburg, M. Prins, U. Beuers and C. J. Weegink
Journal of addiction medicine Jan-Feb 2014;8(1):53-8. doi: 10.1097/adm.0000000000000006

Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists 
E. Lebovics and K. Czobor
The American journal of medicine Nov 2014;127(11):e11-4. doi: 10.1016/j.amjmed.2014.10.004 Epub 2014 Oct 13

Gastroenterologists can enhance hepatitis C screening by testing individuals referred for colorectal cancer screening 
L. Lattimer, A. Kumar, A. Sekaran and M. Borum
Journal of viral hepatitis Oct 2014;21(10):e135. doi: 10.1111/jvh.12221

Hepatitis C, from screening to treatment, a revolution 
K. Lacombe
Journal of the International AIDS Society 2014;17(4 Suppl 3):19499. doi: 10.7448/ias.17.4.19499

Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland 
G. McAllister, H. Innes, A. McLeod, J. F. Dillon, P. C. Hayes, R. Fox, S. T. Barclay, K. Templeton, C. Aitken, R. Gunson, D. Goldberg and S. J. Hutchinson
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology Nov 2014;61(3):359-64. doi: 10.1016/j.jcv.2014.09.004 Epub 2014 Sep 16

Screening for HCV 
F. G. Kouyoumdjian, A. Orkin, K. Dooling and M. Schwandt
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne Mar 4 2014;186(4):294. doi: 10.1503/cmaj.114-0017

Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infection 
A. Liapakis and J. K. Lim
Hepatology (Baltimore, Md.) Aug 2013;58(2):822-6. doi: 10.1002/hep.26552

Current progress in development of hepatitis C virus vaccines 
T. J. Liang
Nature medicine Jul 2013;19(7):869-78. doi: 10.1038/nm.3183

A multicentre survey of hepatitis C awareness in a high-risk population 
T. Kanaan, A. Liu, M. Leroi and R. Nanan
Journal of paediatrics and child health Aug 2013;49(8):649-53. doi: 10.1111/jpc.12259

[Epidemiology of viral hepatitis] 
B. Kaic, T. Vilibic-Cavlek, S. K. Filipovic, T. Nemeth-Blazic, I. Pem-Novosel, V. V. Vucina, A. Simunovic, M. Zajec, I. Radic, J. Pavlic, M. Glamocanin and I. Gjenero-Margan
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti Oct 2013;67(4):273-9. doi:

Best strategies for global HCV eradication 
L. M. Hagan and R. F. Schinazi
Liver international : official journal of the International Association for the Study of the Liver Feb 2013;33 Suppl 1():68-79. doi: 10.1111/liv.12063

Missed opportunities for hepatitis C testing and other opportunistic health care 
M. M. Islam
American journal of public health Dec 2013;103(12):e6. doi: 10.2105/ajph.2013.301611 Epub 2013 Oct 17

Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements 
J. Grebely, G. V. Matthews, A. R. Lloyd and G. J. Dore
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Oct 2013;57(7):1014-20. doi: 10.1093/cid/cit377 Epub 2013 May 31

Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection 
R. Fretz, F. Negro, P. Bruggmann, D. Lavanchy, A. De Gottardi, I. Pache, V. Masserey Spicher and A. Cerny
Swiss medical weekly May 17 2013;143():w13793. doi: 10.4414/smw.2013.13793

[TORCH serology and group B Streptococcus screening analysis in the population of a maternity] 
D. Lito, T. Francisco, I. Salva, Md Tavares, R. Oliveira and M. T. Neto
Acta medica portuguesa Sep-Oct 2013;26(5):549-54. doi: Epub 2013 Oct 31

Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic 
A. Jewett, A. A. Al-Tayyib, L. Ginnett and B. D. Smith
AIDS research and treatment 2013;2013():528904. doi: 10.1155/2013/528904 Epub 2013 Dec 22

Hepatitis C virus testing of persons born during 1945-1965 
R. B. Lynn
Annals of internal medicine May 7 2013;158(9):704. doi: 10.7326/0003-4819-158-9-201305070-00014

[Hepatitis C in French prisons] 
O. Segeral and M. Hagege
Soins; la revue de reference infirmiere Nov 2013;(780):43-5. doi:

Targeted drugs to tackle hepatitis C 
B. Mole
Nature May 2 2013;497(7447):18-9. doi: 10.1038/497018a

Expanded hepatitis C virus screening recommendations promote opportunities for care and cure 
Q. Ngo-Metzger, J. W. Ward and R. O. Valdiserri
Annals of internal medicine Sep 3 2013;159(5):364-5. doi: 10.7326/0003-4819-159-5-201309030-00675

Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-alpha therapy necessary? 
C. T. Reid, C. De Gascun, W. Hall, P. Collins, A. Lally and B. Kirby
The British journal of dermatology Dec 2013;169(6):1319-21. doi: 10.1111/bjd.12598

Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection 
M. W. Russo, T. Narang, L. Eskind, D. Hayes, V. Casingal, P. P. Purdum, J. S. Hanson, W. Ahrens, J. Norton and H. Bonkovsky
Digestive diseases and sciences Oct 2013;58(10):3010-6. doi: 10.1007/s10620-013-2749-z Epub 2013 Jun 29

Viral hepatitis in alcohol-dependent inpatients: prevalence, risk factors, and treatment uptake 
C. S. Schmidt, D. Schon, B. Schulte, S. Luth, S. Polywka and J. Reimer
Journal of addiction medicine Nov-Dec 2013;7(6):417-21. doi: 10.1097/ADM.0b013e3182a50817

[Screening for opportunistic infections and vaccination before introduction of biologic therapy] 
B. M. Sincic and A. Vince
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti Apr 2013;67(2):165-70. doi:

Hepatitis C virus testing of persons born during 1945-1965. In response 
B. D. Smith, D. Holtzman and J. W. Ward
Annals of internal medicine May 7 2013;158(9):705. doi: 10.7326/0003-4819-158-9-201305070-00016

Impact of new therapeutics for hepatitis C virus infection in incarcerated populations 
A. S. Spaulding, A. Y. Kim, A. J. Harzke, J. C. Sullivan, B. P. Linas, A. Brewer, J. Dickert, B. H. McGovern, L. B. Strick, R. Trestman and W. J. Ferguson
Topics in antiviral medicine Feb-Mar 2013;21(1):27-35. doi:

HIV, hepatitis and syphilis prevalence and correlates of condom use during anal sex among men who have sex with men in the Republic of Moldova 
L. Zohrabyan, L. Johnston, O. Scutelniciuc, A. Iovita, L. Todirascu, T. Costin, V. Plesca, T. Cotelnic-Harea and G. Ionascu
International journal of STD & AIDS May 2013;24(5):357-64. doi: 10.1177/0956462412472808 Epub 2013 Jun 14

[Viral hepatitis. Prevention, screening and research] 
A. de la Briere
Soins; la revue de reference infirmiere Nov 2013;(780):19. doi:

HCV burden in Europe and the possible impact of current treatment 
P. Mathurin
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Sep 30 2013;45 Suppl 5():S314-7. doi: 10.1016/j.dld.2013.07.009

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting 
M. Brandolini, S. Novati, A. De Silvestri, C. Tinelli, S. F. Patruno, R. Ranieri and E. Seminari
BMC public health Oct 20 2013;13():981. doi: 10.1186/1471-2458-13-981